According to a new report, published by KBV research, The Global Orthopedic Regenerative Surgical Products Market size is expected to reach $5.4 billion by 2030, rising at a market growth of 4.2% CAGR during the forecast period.
The Ambulatory Surgical Centers segment would register a CAGR of 4.9% during (2023 - 2030). The use of more and more products in ASCs for medical procedures and pain management is responsible for the expansion of the segment. Ambulatory surgery centers (ASCs), also known as outpatient surgery centers, same-day surgery centers, or surgicenters, are medical facilities where surgeries are effectively carried out, do not necessitate an overnight hospital stay, and are relatively less complicated.
The Joint Reconstruction segment is leading the Global Orthopedic Regenerative Surgical Products Market by Application in 2022; thereby, achieving a market value of $1.8 billion by 2030. The segment is expanding due to growing surgical procedures, increasing regenerative joint reconstruction solutions acceptance, and technical improvements. Knee problems can develop over time in the form of cartilage damage, ongoing inflammation, or wear and tear depending on how much force the knee joint has been subjected to over the years.
The Allografts segment would showcase a CAGR of 4.7% during (2023 - 2030). The segment is expanding as more allografts, including fresh-frozen meniscal allografts, soft tissue allografts, osteochondral allografts, and off-the-shelf cartilage, are being used. Allografts are utilized in various surgeries to treat pain, restore limb function, save lives, and more.
The North America region dominated the Global Orthopedic Regenerative Surgical Products Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $2.1 billion by 2030. The Europe market is poised to grow at a CAGR of 3.8% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 4.8% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/orthopedic-regenerative-surgical-products-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of MiMedx Group, Inc., Vericel Corporation, Baxter International, Inc., Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew, Arthrex, Inc., BioTissue Holdings, Inc., VSY Biotechnology GmbH and Aptissen S.A.
By End-use
By Application
By Product
By Geography
Companies Profiled
Unique Offerings 
